Medtronic Inc., the largest maker of heart devices, said it received a subpoena from the U.S. Attorney in western New York related to sales, marketing and reimbursement practices for its brain stimulation products.
Medtronic received the U.S. inquiry on Oct. 14 and is cooperating with the investigation, the Minneapolis-based company said today in a regulatory filing.
